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Abstract
Background:	There	is	a	significant	association	between	intrauterine	infection-associated	inflammatory
responses	and	such	pregnancy	complications	as	abortion	and	preterm	labor.	Here,	we	aimed	to
investigate	anti-inflammatory	effects	of	1,25	(OH)2	D3	on	pro-inflammatory	cytokines	secretion	and
expression	of	TLR2,	TLR4	and	MyD88	in	endometrial	stromal	cells	(ESCs)	and	whole	endometrial	cells
(WECs).	
Method:	WECs	were	treated	with	either	lipopolysaccharide	(LPS)	or	lipoteichoic	acid	(LTA)	and	ESCs
were	treated	with	LPS.	IL-6,	IL8	and	TNF-α	were	quantified	using	ELISA	technique.	TLR2,	TLR4	and
MyD88	expression	were	assessed	by	RT-qPCR.	TLR4	expression	at	the	protein	level	was	studied	by
Western	blot	technique.
Results:	1,25	(OH)2	D3	significantly	reduced	TNF-α	production	in	LPS-activated	ESCs	and	TNF-α	and
IL-6	production	by	LTA-stimulated	WECs.	In	contrast,	1,25	(OH)2	D3	pre-treatment	increased
production	of	IL-8	by	LPS-	and	LTA-stimulated	endometrial	cells.	1,25	(OH)2	D3	pre-treatment
markedly	reduced	LPS-induced	TLR-4	protein	expression	by	ESCs.	LPS	treatment	of	ESCs	significantly
induced	MyD88	gene	expression.	This	effect	was	reversed	when	these	cells	were	pre-treated	with
1,25	(OH)2	D3	before	stimulation	with	LPS.
Conclusion:	1,25	(OH)2	D3	is	an	immunomodulatory	molecule	essential	for	maintenance	of
endometrial	immune	homeostasis	through	controlling	potentially	harmful	inflammatory	responses
associated	with	female	reproductive	tract	infections.	Key	words:	Vitamin	D3,	Endometrium,
Inflammation,	Toll	like	receptors,	Pro-inflammatory	cytokines
Background:
Intrauterine	infections	during	pregnancy	are	among	the	leading	cause	of	pregnancy-associated
complications	such	preterm	labor,	preeclampsia	and	abortion	[1].	Endometrium,	where	implantation
occurs,	should	govern	a	finely-tuned	and	controlled	immune	responses	against	developing	embryo
and	at	the	same	time	prevent	ascending	infections	which	could	be	potentially	harmful	to	gestation.
This	tissue	is	influenced	by	pathogens	invading	vagina	and	cervix	resulting	to	endometrial	infection
and	pregnancy	failure	complications.	Thus,	to	accomplish	a	normal	pregnancy,	there	should	be
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intrinsic	mechanisms	controlling	infections	in	the	endometrium	[2].
Toll	like	receptors	(TLRs)	are	the	main	trigger	of	innate	immune	responses	[3].	Up	to	now,	ten	TLR
members	have	been	identified	in	human	and	each	member	recognizes	specific	pathogen-associated
molecular	patterns	(PAMPs).	TLRs	play	an	important	role	in	immune	defense	against	pathogens	in
such	mucosa	bearing	organs	as	respiratory	and	digestive	tracts	[4].	Data	collected	during	the	past
decade	also	highlighted	their	eminent	role	in	immunity	of	reproductive	tract.	A	plenty	of	reports	have
shown	the	expression	of	TLR1-6	and	9	in	human	endometrium	[5,	6].	At	the	protein	level,
immunohistochemical	experiments	have	also	confirmed	presence	of	TLR1-6	at	different	areas	of
female	reproductive	tract	(FRT)	[7].	TLRs	signal	through	the	recruitment	of	specific	adaptor
molecules.	Binding	of	TLR2-4	to	PAMPs	recruit	myeloid	differentiation	primary-	response	protein	88
(MyD88),	the	key	protein	adapter	in	signal	transduction	of	TLRs,	leading	to	activation	of	JNK,	NF-κB
and	P38	MAP-kinase	and	expression	of	pro-inflammtory	cytokines	such	as	TNF-α,	IL-6	and	IL-1	[8].
While	pro-inflammatory	cytokine	responses	are	essential	for	the	early	and	late	events	of	pregnancy,
an	uncontrolled	inflammatory	response	that	may	occur	during	an	unresolved	infection,	could
potentially	lead	to	unfavorable	pregnancy	outcome.	Binding	of	lipopoysaccharide	(LPS)	to	TLR4
induces	production	of	pro-inflammatory	cytokines	from	trophoblasts	and	binding	of	lipoteichoic	acid
(LTA)	to	TLR2	reduces	longevity	of	these	cells	and	induce	their	apoptosis	which	has	negative	effects
on	placental	growth	and	gestation	[9].	There	are	evidence	showing	association	of	pro-inflamatory
cytokines	and	poor	ourcom	pf	pregnany.	Injection	of	TNF-α,	IFN-γ	and	IL-2	to	pregnant	mice	inhibits
trophoblasts	growth	and	leads	to	abortion	[10].	Some	clinical	studies	also	indicated	that	serum	levels
of	pro-inflammatory	cytokines	in	women	with	history	of	spontanuous	abortion	are	elevated	compared
with	normal	controls	[11].	Indeed,	significant	amount	of	pro-inflammatory	cytokines	such	as	IL-1,	TNF-
α,	IL-6	and	IL-8	present	in	aminotic	fluid	of	women	who	have	experienced	preterm	birth	[12].
Therfore,	therapeutic	modalitis	for	controling	infection-associated	inflammatory	responses	during
pregnancy	would	be	desirable.
1,25	dihydroxycholecalciferol	(1,25	(OH)2	D3)	is	the	active	form	of	vitamin	D3	which	beside
regulating	clacium	and	bone	metabolism,	has	potent	immunomodulatory	features	[13].	Biological
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effects	of	1,25	(OH)2	D3	are	exerted	through	its	receptor;	vitamin	D	receptor	(VDR)	which	is	a
member	of	nuclear	superfamily	receptors	and	is	expressed	in	many	tissues	including	male	and	female
reproductive	tract	[14–16].	1,25	(OH)2	D3	modulates	pro-inflammatory	cytokines	production	through
interfering	with	nuclear	transcription	factors	such	as	NF-AT	and	NF-κB	or	via	direct	interaction	with
vitamin	D3	response	element	in	the	promotor	region	of	those	cytokines	which	compromises
transcription	of	key	Th1	cytokines	such	as;	IL2	and	IFN-γ	and	shifts	immune	response	towards	a	Th2
profile.	1,25	(OH)2	D3	also	conducts	its	anti-inflammatory	action	by	reducing	MHCΙΙ	and	co-
stimulatory	molecules	expression	on	and	inhibition	of	IL-12	production	by	antigen	presenting	cells
preventing	T	cell	activation	by	a	DC-dependent	mechanism	[17,	18].	There	are	few	studies	addressing
immunomodulatory	effects	of	1,25	(OH)2	D3	on	TLRs	expression	in	monocytes	and	macrophages	[19],
but	threre	is	no	evidence	on	potential	immunomodulatory	activity	of	1,25	(OH)2	D3	on	TLR-mediated
endometrial	inflammatory	responses.	Here	we	hypothesized	that	1,25	(OH)2	D3	could	amliorate
inflammatory	resposes	associted	with	stimulation	of	human	endometrial	cells	with	TLR2	and	TLR4
ligands.
Methods	And	Materials:
Subjects:
Ethical	committee	of	Avicenna	Research	Institute	approved	all	experiments	in	this	study	and	samples
were	collected	after	getting	signed	consent	forms	from	participants.	Endometrial	tissues	were
obtained	from	fifteen	apparently	normal	women	between	25–45	years	of	age	referring	to	Avicenna
infertility	clinic	for	hysteroscopic	tubal	ligation	who	had	no	evidence	of	pathology	in	their
hysteroscopic	evaluations.	Participants	had	no	history	of	infertility,	miscarriage	or	preeclampsia,
thyroid	disease,	sign	of	vaginal	infection	or	confounding	pathology	such	as	myoma	in	their
endometrium	and	all	had	history	of	at	least	one	successful	delivery.	All	subjects	had	regular
menstrual	cycles	and	did	not	take	vitamin	D3	or	hormone	in	the	last	three	months.
Sample	collection:
Endometrial	samples	were	collected	by	gynecologists	using	pipelle	pipette	in	proliferative	phase	of
menstrual	cycle	and	transferred	to	the	laboratory	in	a	cold	chain	in	DMEM	containing	antibiotics	in	the
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sterile	condition.	Samples	were	divided	into	three	parts	for	pathological	examination,	RNA	extraction,
and	cell	isolation.	Sample	for	RNA	extraction	was	immediately	immersed	in	RNAlater	and	frozen	at
-20ᵒ	C.
Isolation	of	whole	endometrial	cells	(WECs)	and	stromal	cells	(ESCs)
Isolation	of	WECs	and	ECSs	were	preformed	according	to	the	protocol	published	elsewhere	[20].	In
brief,	tissues	pieces	were	cut	into	small	pieces	and	digested	for	1.5	h	at	37ᵒ	C	with	collagenase	D	and
DNAse	(Roche,	USA).	Isolated	cells	were	used	as	WECs.	For	isolation	of	ESCs,	a	part	of	WECs	was
cultured	for	24	h	and	adherent	cells	were	collected.	Purity	of	isolated	ESCs	were	determined	by
immunofluorescent	staining	and	flow	cytometry.	Vimentin+,	nestin+,	cytokeratin-,	CD10 + and	CD45-
cells	were	regarded	as	ESCs	[20].
Treatment	with	LPS,	LTA	and	1,25	(OH)2	D3
We	previously	showed	that	WECs	expressed	TLR2	and	TLR4,	while	ESCs	only	expressed	TLR4	[20]	and
therefore;	in	this	study	WECs	were	treated	with	either	LPS	or	LTA,	while	ESCs	were	exposed	to	only
LPS.	Indeed,	using	a	kinetic	study	on	production	of	pro-inflammatory	cytokines	following	LPS	and	LTA
treatment	of	WECs	and	ESCs,	we	had	previously	shown	that	LTA	with	the	concentration	of	1000	ng/ml
were	optimal	doses	to	drive	pro-inflammatory	cytokines	by	those	cell	types	[20].	To	this	end,	WECs
and	ESCs	were	treated	with	pre-optimized	concentration	of	LTA	or	with	100-10000	ng/ml	LPS.
Moreover,	according	to	our	previous	reports[15,	16,	21],	physiologic	concentration	of	vitamin	D3	was
selected	for	assessing	its	effects	on	LPS-	and	LTA-induced	target	genes	and	proteins	expression.	To
evaluate	the	effects	of	1,25	(OH)2	D3	on	cytokines	production	by	WECs	and	ESCs,	1 × 105	cells	were
cultured	in	wells	of	96	well	culture	plate	and	treated	with	10− 7M	1,25	(OH)2	D3	for	48	h	followed	by
LPS	or	LTA	stimulation	for	24	h.	Conditioned	media	were	then	harvested	and	stored	at	-70ᵒ	C	cytokine
assay.	In	order	to	assess	potential	effect	of	1,25	(OH)2	D3	on	modulation	of	LPS-	or	LTA-stimulated
expression	of	TLR2,	TLR4	and	MyD88,	106	endometrial	cells	were	cultured	in	6	well	plates	and	treated
with	10− 7M	1,25	(OH)2	D3	for	48	h.	After	then	pre-optimized	concentrations	of	LPS	or	LTA	was	added
to	the	wells	for	8	h.	Based	on	the	results	of	preliminary	kinetic	experiments,	this	time	period	was
6
optimal	for	gene	expression	following	endometrial	cell	stimulation	with	either	LPS	or	LTA.	After	then,
cells	were	harvested	in	RNA	Bee	and	stored	at	-70ᵒ	C.
Cytokine	assay:
The	concentrations	of	IL-6	(ebioscience,	USA),	IL-8	and	TNF-α	(BD	biosciences,	USA)	were	measured	in
cell	culture	supernatants	by	sandwich	ELISA.	The	minimal	detection	limit	for	aforesaid	cytokine	assay
sets	were	7.5,	3.1,	and	3.1	pg/ml	for	TNF-α,	IL-6	and	IL-8,	respectively.	All	measurements	were
performed	in	triplicate.
Reverse	transcriptase	real	time	quantitative	polymerase	chain	reaction	(RT-qPCR):
Total	RNA	was	extracted	using	commercial	RNA	extraction	kit	(Biosite-Sweden)	according	to
manufacturer’s	protocol.	The	cDNA	was	synthesized	for	each	sample	using	reverse	transcriptase
(Fermentas–Lithuania)	based	on	the	manufacturer	instructions.	The	following	primers	were	used	for
RT-qPCR:	TLR2	forward:	5’-ATTGTGCCCATTGCTCTTTC-3’	Reverse:	5’-TTCTTCCTTGGAGAGGCTGA-3’
[22];	TLR4	forward:	5’-	GCTTCTTGCTGGCTGCATAA-3’	reverse:	GAAATGGAGGCACCCCTTC-3’	[23];
MyD88	forward:	5’-GAGCGTTTCGATGCCTTCAT-3’	reverse:	5’-	CGGATCATCTCCTGCACAAA-3’	[24]	and
β-actin	was	used	as	a	housekeeping	gene	with	following	primers:	Forward:	5’-	AGCCTCGCCTTTGCCGA-
3’	reverse:	5’-	CTGGTGCCTGGGGCG-C3’[25].	To	carry	out	qRT-PCR,	SYBR	Green	(Takara)	master	mix
was	used.	The	amplification	efficiency	of	target	and	reference	genes	were	determined,	then
comparative	ΔΔCT	method	was	used	to	analyze	qRT-PCR	data.	Target	genes	expression	were
relatively	compared	and	results	were	analyzed	by	Rest-rg	software.
Western	Blot:
TLR4	expression	at	the	protein	level	was	also	studied	using	western	blot	according	to	the	protocol
published	elsewhere	[26].	In	brief,	cell	lysate	was	prepared	in	a	lysis	buffer	containing	%2	SDS,	10%
glycerol,	50	mM	Dithiothreitol,	and	0.1%	Bromophenol	blue.	Protein	content	of	each	cell	lysate	was
measured	using	BCA	assay.	Proteins	were	resolved	in	a	10%	SDS-PAGE	gel	and	bands	were
electrotransfered	onto	the	PVDF	membrane	(Millipore,	Bedford,	USA).	Immunobloting	was	performed
using	goat	anti-human	TLR4	(R&D,	USA)	at	1	µg/ml	for	2	h	followed	by	washing	and	45	min	incubation
with	rabbit	anti-goat	Ig-HRP	(Sinabiotech,	Iran).	Bands	were	visualized	using	ECL	reagent	(GE
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Healthcare,	Sweden).	Membranes	were	later	stripped	using	Western	Re-Probe	(Calbiochem,	SanDiego,
CA,	USA),	re-incubated	for	2	hr	with	agitation	in	polyclonal	rabbit	anti-beta	actin	antibody	(Sigma,
USA)	as	loading	control	followed	by	45	min	incubation	in	HRP-conjugated	sheep	anti-rabbit	Ig
(Sinabiotech)	and	processed	as	above.	In	negative	control	blots,	primary	antibody	was	substituted	by
equivalent	dilutions	of	species-matched	normal	sera.
Data	Analysis
Data	were	expressed	as	Scattor	plot	and	mean.	For	comparison	of	different	groups,	either	T-test	or
one	way	ANOVA	analysis	was	used.	The	relative	expression	of	target	genes	was	normalized	first	with
reference	gene	(β-actin)	and	then	with	corresponding	control.	All	data	were	analyzed	and	plotted	by
GraphPad	Prism	6.07.
Results
1,25	(OH)2	D3	downregulated	LPS-induced	production	of	pro-inflammatory	cytokines	by	ESCs	and
WECs:
To	assay	the	effect	of	1,25	(OH)2	D3	on	TNF-α,	IL-6	and	IL-8	production	by	ESCs,	these	cells	were	first
primed	with	1,25	(OH)2	D3	before	stimulation	with	LPS.	Concentration	of	cytokines	was	then
measured	in	culture	supernatants.	LPS	increased	TNF-α	production	compared	to	non-treated	control
cells	(p < 0.05).	We	observed	that	1,25	(OH)2	D3	was	able	to	significantly	reduce	TNF-α	production	by
ESCs	(p < 0.05)	(Fig.	1a)	comparing	to	the	corresponding	LPS-treated	controls,	and	non-LPS	treated
control.	Such	treatment	did	not	exert	a	considerable	effect	on	IL-6	production	by	these	cells	(Fig.	1b),
whereas	LPS	raised	IL-6	production	by	ESCs	(p < 0.05)..	In	contrast	to	what	observed	in	case	of	TNF-α,
1,25	(OH)2	D3	raised	production	of	IL-8	at	all	LPS	concentrations	tested	and	non-LPS	treated	control
as	well	(p < 0.01)	(Fig.	1c).	IL-8	was	induced	at	all	LPS	concentrations	comparing	to	non-treated
control	(p < 0.05).	..
Based	on	our	preliminary	results	in	which	LPS	did	not	exert	a	significant	impact	on	TNF-α	production
by	WECs,	effect	of	1,25	(OH)2	D3	on	this	process	was	not	studied.	1,25	(OH)2	D3	reduced	IL-6
production	by	WECs	which	was	already	upregulated	due	to	LPS	treatment	(p < 0.05)	(Fig.	1d).	LPS
caused	increased	level	of	IL-8	production	by	WECs	(p < 0.05).	As	with	ESCs,	1,25	(OH)2	D3
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upregulated	LPS-induced	production	of	IL-8	by	WECs	(p < 0.01)	(Fig.	1e).
1,25	(OH)2	D3	downregulated	LTA-induced	production	of	pro-inflammatory	cytokines	by	WECs:
The	effect	of	1,25	(OH)2	D3	on	pro-inflammatory	cytokines	production	by	WECs	following	LTA
stimulation	was	tested	in	parallel.	Our	data	showed	that	1,25	(OH)2	D3	reduced	basal	level	(p < 0.05)
and	LTA-induced	production	of	TNF-α	(p < 0.01)	(Fig.	2a)	and	IL-6	(p < 0.05 − 0.01)	(Fig.	2b),	while
increased	IL-8	production	(Fig.	2c)	by	LTA-treated	(p < 0.05)	and	non-treated	WECs	(p < 0.01).	Again,
the	effect	of	1,25	(OH)2	D3	on	unstimulated	WECs	mimicked	its	effect	on	LTA-activated	cells.
1,25	(OH)2	D3	reduced	LPS-induced	MyD88	expression	in	ESCc
To	study	whether	TLR4	and	TLR2	signaling	in	WECs	and	ESCs	following	LPS	and	LTA	stimulation	is
potentially	affected	by	1,25	(OH)2	D3	treatment,	expression	of	TLR4,	TLR2	and	MyD88	transcript	was
investigated.	Our	results	showed	that	1,25	(OH)2	D3	neither	affect	expression	of	TLR4	by	LPS-
activated	ESCs	nor	LTA-activated	WECs	(Fig.	3a	and	b).	At	the	protein	level,	however,	1,25	(OH)2	D3
pre-treatment	markedly	reduced	TLR4	protein	expression	by	LPS-stimulated	ESCs	(Fig.	3c).	Of	note,
LPS	treatment	of	ESCs	significantly	induced	MyD88	gene	expression	(p < 0.05).	This	effect	was
reversed	when	ESCs	were	pre-treated	with	1,25	(OH)2	D3	before	stimulation	with	LPS.	1,25	(OH)2	D3
itself	had	also	an	inhibitory	effect	on	basal	level	of	MyD88	expression	in	ESCs	(Fig.	3d).	In	LTA-
activated	WECs,	1,25	(OH)2	D3	did	not	alter	MyD88	gene	expression	(Fig.	3e).
Discussion
Bacterial	and	viral	infections	are	considered	a	serious	threat	to	gestation	and	developing	embryo.
Clinical	studies	have	revealed	a	significant	association	between	pregnancy	complications	and
intrauterine	infections.	It	was	reported	that	infections	account	for	etiology	of	more	than	40%	of
preterm	birth	cases	[27]	and	in	about	80%	of	preterm	births	before	30	weeks	of	gestation	the
footprint	of	infections	can	be	tracked.	Infections	have	also	been	shown	to	be	linked	with	spontaneous
abortion	and	preeclampsia.	The	pathogenesis	behind	infection-induced	pregnancy	complications
comprises	inflammation	and	pro-inflammatory	cytokines	production	by	PAMPs-activated	local	immune
cells	[28].
Endometrium	is	a	site	in	which	a	precise	tuning	of	inflammatory	responses	in	necessary	for	successful
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pregnancy.	It	expresses	a	full	range	of	TLR	molecules	[29]	pointing	to	the	importance	of	local	immune
defense	against	a	wide	spectrum	of	microorganisms.	We	also	previously	showed	that	cultured	human
endometrial	cells	express	TLR2,	TLR4	and	MyD88	[20].	Although	TLRs	are	essential	for	female
reproductive	tract	(FRT)	defense	against	invading	pathogens,	the	lack	of	TLR	negative	regulatory
system	might	be	associated	with	inflammatory	responses	leading	to	harmful	consequences.	1,25
(OH)2	D3	is	a	part	of	such	regulatory	network	known	to	be	effective	in	the	downregulation	of	pro-
inflammatory	cytokine	production	[29,	30],	induction	of	regulatory	T	cells	and	inhibition	of	antigen
presentation	[30].	Notably,	component	of	vitamin	D3	functional	network	is	active	in	male	and	female
reproductive	tract[14,	16,	31],[15].	We	showed	that	human	ESCs	express	vitamin	D	receptor	and	1α
hydroxylase,	the	enzyme	responsible	for	the	production	of	active	form	of	vitamin	D3,	implying	that
these	cells	are	the	target	of	vitamin	D3	action.	Notably,	these	cells	are	also	produce	active	form	of
vitamin	D3	pointing	to	the	central	role	of	this	hormone	in	FRT	[15].
Here,	we	unrevealed	an	unprecedented	action	of	vitamin	D3	in	FRT.	We	showed	that	1,25	(OH)2	D3
significantly	counteract	with	LPS-induced	TNF-α	production	by	ESCs	and	IL-6	production	by	WECs.
Similarly,	1,25	(OH)2	D3	reduced	TNF-α	and	IL-6	production	by	LTA-stimulated	WECs.	Anti-
inflammatory	action	of	1,25(OH)2D3	has	been	reported	earlier	showing	that	this	hormone	prevents
production	of	inflammatory	cytokines	by	monocytes	[32].	It	has	also	been	reported	that	1,25(OH)2D
halts	IL-6,	TNF-α	and	GM-CSF-2	expression	in	primary	culture	of	human	decidua	and
syncytiotrophoblast	[33–35].	Diaz	et	al.	demonstrated	that	in	cultured	human	trophoblasts	calciferol
reduces	TNF-α	gene	expression.	They	also	gave	evidence	that	calciferol	influence	Th1	cytokines
production	through	regulating	TNF-α	function	in	these	cells.	These	findings	imply	that	there	is
genomic	mechanisms	governing	anti-inflammatory	effects	of	calciferol.	There	are	several	genes	such
as;	TNF-α,	IL-6	and	IFN-γ	which	that	are	recognized	by	responsive	elements	to	1,25	(OH)2	D3	[34].
Besides,	vitamin	D	is	a	part	of	FRT	immune	network	which	exerts	an	essential	role	in	anti-bacterial
defense	through	augmenting	macrophage	function	and	anti-bacterial	agent,	cathelicidin	[36].
Despite	of	inhibitory	effect	of	1,25	(OH)2	D3	on	IL-6	and	TNF-α	production,	we	observed	that,	1,25
(OH)2	D3	increased	IL-8	production	in	WECs	and	ESCs.	IL-8	has	chemotactic	effects	on	neutrophils	in
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both	in	vivo	and	in	vitro	and	involved	in	hemostasis	of	innate	immune	system	in	endometrium	[37].
Besides,	it	is	a	potential	growth	factor	for	endometrial	stromal	cell	[38].	In	this	regard,	it	can	be
concluded	that	1,25	(OH)2	D3	have	a	dual	role	in	controlling	inflammatory	responses	of	endometrium
and	at	the	same	time	potentiate	innate	defense	mechanisms	of	endometrium.
Next,	we	showed	that	LPS-induced	upregulation	of	MyD88	gene	expression	in	ESCs	was	normalized
when	these	cells	were	pre-treated	with	1,25	(OH)2	D3.	This	effect	may	explain	in	part	aforementioned
anti-inflammatory	action	of	1,25	(OH)2	D3	on	ESCs.	MyD88	acts	as	the	common	adaptor	protein	for
TLR2	and	TLR4	and	downregulation	of	MyD88	expression	could	expectedly	inhibits	TLR2	and	TLR4
signaling	leading	to	diminished	levels	of	pro-inflammatory	cytokines	production.	Moreover,	we	found
that	1,25	(OH)2	D3	pre-treatment	markedly	reduced	LPS-induced	TLR-4	protein	expression	by	ESCs.
This	effect	could	synergistically	act	with	MyD88	downregulation	and	strongly	inhibit	LPS-induced
inflammatory	responses.	In	line	with	our	findings,	Sadeghi	et	al.	demonstrated	that	1,25	(OH)2D3
amplify	anti-microbial	functions	in	myeloid	cells	whereas	it	decreases	TLR2	and	TLR4	expression	in
monocytes	in	which	it	creates	a	condition	less	sensitive	to	PAMPs	[39].	Indeed,	Do	et	al.	ascribed	high
expression	of	TLR	on	monocytes	to	low	1,25(OH)2D3	serum	level	in	patients	with	Behcet's	disease
[40].	Despite	our	finding	at	the	protein	level,	we	did	not	observe	negative	regulatory	effect	of	1,25
(OH)2D3	on	TLR2	and	TLR4	gene	expression	which	could	be	attributed	to	the	mRNA	instability.
Indeed,	1,25	(OH)2	D3	only	succeeded	to	dampen	MyD88	expression	in	ESCs	stimulated	with	LPS	but
failed	to	do	the	same	in	WECs	stimulated	with	LTA.	TLR4	is	MYD88	dependent	[20],	while	this	adaptor
protein	is	not	critical	for	TLR2	signaling	[41].	We	also	demonstrated	that	LTA	could	not	cause	a	raise
of	MyD88	gene	expression	in	WECs	[20].	In	this	context,	downregulation	of	pro-inflammatory
cytokines	in	LTA-treated	WECs	following	1,25	(OH)2	D3	treatment	might	be	due	to	the	effect	of	this
hormone	on	collateral	signaling	adaptor	proteins.
Taken	all	these,	it	can	be	inferred	that	1,25	(OH)2	D3	is	an	immunomodulatory	molecule	essential	for
maintenance	of	endometrial	immune	homeostasis	through	controlling	potentially	harmful
inflammatory	responses	and	brushing	off	unwanted	immune	reactions	associated	with	FRT	infections.
In	line	with	this	conclusion,	recent	findings	also	linked	vitamin	D	deficiency	to	increased	risk	of	FRT
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infections	and	production	of	pro-inflammatory	cytokines	[42].	Further	clinical	studies	are	needed	to
explore	full	spectrum	of	other	immunomodulatory	facets	of	1,25	(OH)2	D3	in	female	reproductive
tract.
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Figure	1
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Effect	of	1,25	(OH)2	D3	on	pro-inflammatory	cytokine	production	by	LPS-activated	ESCs	and
WECs.	Endometrial	stromal	cells	(ESCs)	(a-c)	and	whole	endometrial	cells	(WECs)	(d	and	e)
were	pre-treated	with	1,25	(OH)2	D3	before	stimulation	with	LPS	(100-10000	ng/ml)	and
levels	of	TNF-α	(a),	IL-6	(b	and	d)	and	IL-8	(c	and	e)	were	measured	in	culture	supernatants.
(n=10),	*,€:	p<0.05.	**,€€:	p<0.01.	€:	compared	to	control	and	*:	compared	to
corresponding	LPS-stimulated	cells	without	1,25	(OH)2	D3	pre-treatment.
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Figure	2
Effect	of	1,25	(OH)2	D3	on	pro-inflammatory	cytokine	production	by	LTA-activated	WECs.
Whole	endometrial	cells	(WECs)	were	pre-treated	with	1,25	(OH)2	D3	before	stimulation
with	LTA	(1000	ng/ml)	and	levels	of	TNF-α	(a),	IL-6	(b)	and	IL-8	(c)	were	measured	in	culture
supernatants.	(n=10),	*,€:	p<0.05.	**,€€:	p<0.01.	€:	compared	to	control	and	*:	compared
to	corresponding	LPS-stimulated	cells	without	1,25	(OH)2	D3	pre-treatment.
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Figure	3
22
Effect	of	1,25	(OH)2	D3	on	TLR2,	TLR4	and	MyD88	expression	in	ESCs	and	WECs.
Endometrial	stromal	cells	(ESCs)	(a	and	d)	and	whole	endometrial	cells	(WECs)	(b	and	e)
were	pre-treated	with	1,25	(OH)2	D3	before	stimulation	with	LPS	or	LTA	and	the	expression
of	TLR4	(a),	TLR2	(b)	and	MyD88	(d	and	e)	transcripts	were	quantified	by	real	time	PCR.
Expression	of	TLR4	protein	was	also	investigated	in	ESCs	after	pre-treatment	with	1,25
(OH)2	D3	and	stimulation	with	LPS	(c).	Relative	expression	was	calculated	in	each	group	in
reference	to	corresponding	control.	(n=10),	*:	p<0.05.
